Reply to Giandomenico Roviello, Alberto Bottini, and Daniele Generali's Letter to the Editor re: Karim Fizazi, Kim N. Chi, Johann S. de Bono, et al. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.035. Corticosteroid-associated Adverse Events in Elderly Patients.

Karim Fizazi, Peter De Porre, Anil Londhe, Tracy McGowan, Charles J Ryan

Abstract readLetterComment

In one paragraph

Article in European urology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.3field-weighted citation impact, top 31% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Karim FizaziInstitut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: karim.fizazi@igr.fr.

Peter De PorreJanssen Research & Development, Beerse, Belgium.

Anil LondheJanssen Research & Development, Horsham, PA, USA.

Tracy McGowanJanssen Scientific Affairs, Horsham, PA, USA.

Charles J RyanHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.

Janssen (United States) · USJanssen (Belgium) · BEUCSF Helen Diller Family Comprehensive Cancer Center · USUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Abiraterone AcetatePrednisoneAdrenal Cortex HormonesAgedHumansIncidenceMaleProstatic Neoplasms, Castration-ResistantAbiraterone AcetateAdrenal Cortex HormonesPrednisone

Identifiers

PMID27209539

DOI10.1016/j.eururo.2016.05.005

OpenAlexW4235465373

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.